Cerebrospinal fluid proteome of patients with acute Lyme disease

Journal of Proteome Research

Volumn 11, Issue 10, 2012, Pages 4814-4822

  Angel, Thomas E ^a   Jacobs, Jon M ^a   Smith, Robert P ^b   Pasternack, Mark S ^c   Elias, Susan ^b   Gritsenko, Marina A ^a   Shukla, Anil ^a   Gilmore, Edward C ^c   Mccarthy, Carol ^b   Camp, David G ^a   Smith, Richard D ^a   Warren, H Shaw ^c  

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^b Maine Medical Center Research Institute   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

cerebrospinal fluid; Lyme disease; Lyme neuroborreliosis; mass spectrometry; proteomics

Indexed keywords

PROTEOME;

ADOLESCENT; ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LYME DISEASE; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; SYNAPSE;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; AREA UNDER CURVE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; LIMIT OF DETECTION; LYME NEUROBORRELIOSIS; MALE; METABOLIC NETWORKS AND PATHWAYS; MIDDLE AGED; NERVE TISSUE PROTEINS; PROTEOME; ROC CURVE; YOUNG ADULT;

EID: 84867466178     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr300577p     Document Type: Article

References (45)

1. Casjens, S. R.; Fraser-Liggett, C. M.; Mongodin, E. F.; Qiu, W. G.; Dunn, J. J.; Luft, B. J.; Schutzer, S. E. Whole genome sequence of an unusual Borrelia burgdorferi sensu lato isolate J. Bacteriol. 2011, 193 (6) 1489-90
2. Burgdorfer, W.; Barbour, A. G.; Hayes, S. F.; Benach, J. L.; Grunwaldt, E.; Davis, J. P. Lyme disease-a tick-borne spirochetosis? Science 1982, 216 (4552) 1317-9
3. Alghaferi, M. Y.; Anderson, J. M.; Park, J.; Auwaerter, P. G.; Aucott, J. N.; Norris, D. E.; Dumler, J. S. Borrelia burgdorferi ospC heterogeneity among human and murine isolates from a defined region of northern Maryland and southern Pennsylvania: Lack of correlation with invasive and noninvasive genotypes J. Clin. Microbiol. 2005, 43 (4) 1879-84
4. Seinost, G.; Dykhuizen, D. E.; Dattwyler, R. J.; Golde, W. T.; Dunn, J. J.; Wang, I. N.; Wormser, G. P.; Schriefer, M. E.; Luft, B. J. Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans Infect. Immun. 1999, 67 (7) 3518-24
5. Hildenbrand, P.; Craven, D. E.; Jones, R.; Nemeskal, P. Lyme neuroborreliosis: manifestations of a rapidly emerging zoonosis Am. J. Neuroradiol. 2009, 30 (6) 1079-87
6. Halperin, J. J. Nervous system lyme disease: diagnosis and treatment Rev. Neurol. Dis. 2009, 6 (1) 4-12
7. Schutzer, S. E.; Liu, T.; Natelson, B. H.; Angel, T. E.; Schepmoes, A. A.; Purvine, S. O.; Hixson, K. K.; Lipton, M. S.; Camp, D. G.; Coyle, P. K.; Smith, R. D.; Bergquist, J. Establishing the proteome of normal human cerebrospinal fluid PLoS One 2010, 5 (6) e10980
8. Schutzer, S. E.; Angel, T. E.; Liu, T.; Schepmoes, A. A.; Clauss, T. R.; Adkins, J. N.; Camp, D. G.; Holland, B. K.; Bergquist, J.; Coyle, P. K.; Smith, R. D.; Fallon, B. A.; Natelson, B. H. Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome Plos One 2011, 6 (2) e17287
9. Maarouf, C. L.; Andacht, T. M.; Kokjohn, T. A.; Castano, E. M.; Sue, L. I.; Beach, T. G.; Roher, A. E. Proteomic analysis of Alzheimers disease cerebrospinal fluid from neuropathologically diagnosed subjects Curr. Alzheimer Res. 2009, 6 (4) 399-406
10. Stoop, M. P.; Dekker, L. J.; Titulaer, M. K.; Lamers, R. J.; Burgers, P. C.; Sillevis Smitt, P. A.; van Gool, A. J.; Luider, T. M.; Hintzen, R. Q. Quantitative matrix-assisted laser desorption ionization-fourier transform ion cyclotron resonance (MALDI-FT-ICR) peptide profiling and identification of multiple-sclerosis-related proteins J. Proteome Res. 2009, 8 (3) 1404-14
11. Constantinescu, R.; Andreasson, U.; Li, S.; Podust, V. N.; Mattsson, N.; Anckarsater, R.; Anckarsater, H.; Rosengren, L.; Holmberg, B.; Blennow, K.; Wikkelso, C.; Ruetschi, U.; Zetterberg, H. Proteomic profiling of cerebrospinal fluid in parkinsonian disorders Parkinsonism Relat. Disord. 2010, 16 (8) 545-9
12. Kroksveen, A. C.; Opsahl, J. A.; Aye, T. T.; Ulvik, R. J.; Berven, F. S. Proteomics of human cerebrospinal fluid: Discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics J. Proteomics 2011, 74 (4) 371-88
13. Centers for Disease Control and Prevention Lyme disease - United States, 1995 Morb. Mortal Wkly Rep. 1996, 45 (23) 481-4
14. Liu, T.; Qian, W. J.; Gritsenko, M. A.; Xiao, W. Z.; Moldawer, L. L.; Kaushal, A.; Monroe, M. E.; Varnum, S. M.; Moore, R. J.; Purvine, S. O.; Maier, R. V.; Davis, R. W.; Tompkins, R. G.; Camp, D. G.; Smith, R. D.; Injury, I. H. R. High dynamic range characterization of the trauma patient plasma proteome Mol. Cell. Proteomics 2006, 5 (10) 1899-1913
15. Livesay, E. A.; Tang, K.; Taylor, B. K.; Buschbach, M. A.; Hopkins, D. F.; LaMarche, B. L.; Zhao, R.; Shen, Y.; Orton, D. J.; Moore, R. J.; Kelly, R. T.; Udseth, H. R.; Smith, R. D. Fully automated four-column capillary LC-MS system for maximizing throughput in proteomic analyses Anal. Chem. 2008, 80 (1) 294-302
16. Shaffer, S. A.; Prior, D. C.; Anderson, G. A.; Udseth, H. R.; Smith, R. D. An ion funnel interface for improved ion focusing and sensitivity using electrospray ionization mass spectrometry Anal. Chem. 1998, 70 (19) 4111-9
17. Polpitiya, A. D.; Qian, W. J.; Jaitly, N.; Petyuk, V. A.; Adkins, J. N.; Camp, D. G., 2nd; Anderson, G. A.; Smith, R. D. DAnTE: a statistical tool for quantitative analysis of -omics data Bioinformatics 2008, 24 (13) 1556-8
18. Bayes, A.; van de Lagemaat, L. N.; Collins, M. O.; Croning, M. D.; Whittle, I. R.; Choudhary, J. S.; Grant, S. G. Characterization of the proteome, diseases and evolution of the human postsynaptic density Nat. Neurosci. 2011, 14 (1) 19-21
19. Myers, T. A.; Kaushal, D.; Philipp, M. T. Microglia are mediators of Borrelia burgdorferi-induced apoptosis in SH-SY5Y neuronal cells PLoS Pathog. 2009, 5 (11) e1000659
20. Ramesh, G.; Borda, J. T.; Gill, A.; Ribka, E. P.; Morici, L. A.; Mottram, P.; Martin, D. S.; Jacobs, M. B.; Didier, P. J.; Philipp, M. T. Possible role of glial cells in the onset and progression of Lyme neuroborreliosis J. Neuroinflammation 2009, 6, 23
21. Zimmer, J. S.; Monroe, M. E.; Qian, W. J.; Smith, R. D. Advances in proteomics data analysis and display using an accurate mass and time tag approach Mass Spectrom Rev 2006, 25 (3) 450-82
22. Johanson, C. E.; Duncan, J. A., 3rd; Klinge, P. M.; Brinker, T.; Stopa, E. G.; Silverberg, G. D. Multiplicity of cerebrospinal fluid functions: New challenges in health and disease Cerebrospinal Fluid Res. 2008, 5, 10
23. Regeniter, A.; Kuhle, J.; Mehling, M.; Moller, H.; Wurster, U.; Freidank, H.; Siede, W. H. A modern approach to CSF analysis: pathophysiology, clinical application, proof of concept and laboratory reporting Clin. Neurol. Neurosurg. 2009, 111 (4) 313-8
24. Ramesh, G.; Borda, J. T.; Dufour, J.; Kaushal, D.; Ramamoorthy, R.; Lackner, A. A.; Philipp, M. T. Interaction of the Lyme disease spirochete Borrelia burgdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis Am. J. Pathol. 2008, 173 (5) 1415-27
25. Goonetilleke, U. R.; Scarborough, M.; Ward, S. A.; Gordon, S. B. Proteomic analysis of cerebrospinal fluid in pneumococcal meningitis reveals potential biomarkers associated with survival J. Infect. Dis. 2010, 202 (4) 542-50
26. Gasse, T.; Murr, C.; Meyersbach, P.; Schmutzhard, E.; Wachter, H.; Fuchs, D. Neopterin Production and Tryptophan Degradation in Acute Lyme Neuroborreliosis Versus Late Lyme Encephalopathy Eur. J. Clin. Chem. Clin. Biochem. 1994, 32 (9) 685-9
27. Mattsson, N.; Bremell, D.; Anckarsater, R.; Blennow, K.; Anckarsater, H.; Zetterberg, H.; Hagberg, L. Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism BMC Neurol. 2010, 10, 51
28. Gisslen, M.; Krut, J.; Andreasson, U.; Blennow, K.; Cinque, P.; Brew, B. J.; Spudich, S.; Hagberg, L.; Rosengren, L.; Price, R. W.; Zetterberg, H. Amyloid and tau cerebrospinal fluid biomarkers in HIV infection BMC Neurol. 2009, 9, 63
29. Angel, T. E.; Jacobs, J. M.; Spudich, S. S.; Gritsenko, M. A.; Fuchs, D.; Liegler, T.; Zetterberg, H.; Camp, D. G., 2nd; Price, R. W.; Smith, R. D. The cerebrospinal fluid proteome in HIV infection: change associated with disease severity Clin. Proteomics 2012, 9 (1) 3
30. Iwata, A.; Maruyama, M.; Akagi, T.; Hashikawa, T.; Kanazawa, I.; Tsuji, S.; Nukina, N. Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies Hum. Mol. Genet. 2003, 12 (20) 2625-35
31. Little, S. P.; Dixon, E. P.; Norris, F.; Buckley, W.; Becker, G. W.; Johnson, M.; Dobbins, J. R.; Wyrick, T.; Miller, J. R.; MacKellar, W.; Hepburn, D.; Corvalan, J.; McClure, D.; Liu, X.; Stephenson, D.; Clemens, J.; Johnstone, E. M. Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimers disease brain J. Biol. Chem. 1997, 272 (40) 25135-42
32. Rupprecht, T.; Koedel, U.; Angele, B.; Kastenbauer, S.; Wilske, B.; Pfister, H. W. The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis J. Neurol. 2005, 252, 34-5
33. Rupprecht, T.; Kirschning, C.; Popp, B.; Kastenbauer, S.; Fingerle, V.; Pfister, H. W.; Koedel, U. Borrelia garinii induces CXCL13 production in human monocytes through TLR2 J. Neurol. 2007, 254, 30
34. Marra, C. M.; Tantalo, L. C.; Sahi, S. K.; Maxwell, C. L.; Lukehart, S. A. CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis Sex. Transm. Dis. 2010, 37 (5) 283-7
35. Qian, W. J.; Kaleta, D. T.; Petritis, B. O.; Jiang, H. L.; Liu, T.; Zhang, X.; Mottaz, H. M.; Varnum, S. M.; Camp, D. G.; Huang, L.; Fang, X. M.; Zhang, W. W.; Smith, R. D. Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy Mol. Cell. Proteomics 2008, 7 (10) 1963-73
36. Liu, T.; Hossain, M.; Schepmoes, A. A.; Fillmore, T. L.; Sokoll, L. J.; Kronewitter, S. R.; Izmirlian, G.; Shi, T.; Qian, W.-J.; Leach, R. J.; Thompson, I. M.; Chan, D. W.; Smith, R. D.; Kagan, J.; Srivastava, S.; Rodland, K. D.; Camp, D. G., II Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests J. Proteomics 2012, 75 (15) 4747-57
37. Schwan, T. G.; Piesman, J.; Golde, W. T.; Dolan, M. C.; Rosa, P. A. Induction of an Outer Surface Protein on Borrelia-Burgdorferi during Tick Feeding Proc. Natl. Acad. Sci. U.S.A. 1995, 92 (7) 2909-13
38. Pure, E.; Cuff, C. A. A crucial role for CD44 in inflammation Trends Mol. Med. 2001, 7 (5) 213-21
39. Kawana, H.; Karaki, H.; Higashi, M.; Miyazaki, M.; Hilberg, F.; Kitagawa, M.; Harigaya, K. CD44 suppresses TLR-mediated inflammation J. Immunol. 2008, 180 (6) 4235-45
40. Singh, B.; Su, Y. C.; Riesbeck, K. Vitronectin in bacterial pathogenesis: a host protein used in complement escape and cellular invasion Mol. Microbiol. 2010, 78 (3) 545-60
41. Henningsson, A. J.; Ernerudh, J.; Sandholm, K.; Carlsson, S. A.; Granlund, H.; Jansson, C.; Nyman, D.; Forsberg, P.; Nilsson Ekdahl, K. Complement activation in Lyme neuroborreliosis - increased levels of C1q and C3a in cerebrospinal fluid indicate complement activation in the CNS J. Neuroimmunol. 2007, 183 (1-2) 200-7
42. Ashkar, S.; Weber, G. F.; Panoutsakopoulou, V.; Sanchirico, M. E.; Jansson, M.; Zawaideh, S.; Rittling, S. R.; Denhardt, D. T.; Glimcher, M. J.; Cantor, H. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity Science 2000, 287 (5454) 860-4
43. Marques, A. R. Lyme Disease: A Review Curr. Allergy Asthma Rep. 2010, 10 (1) 13-20
44. Djukic, M.; Schmidt-Samoa, C.; Lange, P.; Spreer, A.; Neubieser, K.; Eiffert, H.; Nau, R.; Schmidt, H. Cerebrospinal fluid findings in adults with acute Lyme neuroborreliosis J. Neurol. 2012, 259 (4) 630-6
45. Tumani, H.; Nolker, G.; Reiber, H. Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis Neurology 1995, 45 (9) 1663-70